Cost-Utility of an Online Education Platform and Diabetes Personal Health Record: Analysis Over Ten Years
Open Access
- 5 January 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 17 (3) , 715-726
Abstract
Background and Aims: My Diabetes My Way (MDMW) is Scotland’s interactive website and mobile app for people with diabetes and their caregivers. It contains multimedia resources for diabetes education and offers access to electronic personal health records. This study aims to assess the cost-utility of MDMW compared with routine diabetes care in people with type 2 diabetes who do not use insulin. Materials and Methods: Analysis used the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model 2. Clinical parameters of MDMW users (n = 2576) were compared with a matched cohort of individuals receiving routine care alone (n = 11 628). Matching criteria: age, diabetes duration, sex, and socioeconomic status. Impact on life expectancy, quality-adjusted life years (QALYs), and costs of treatment and complications were simulated over ten years, including a 10% sensitivity analysis. Results: MDMW cohort: 1670 (64.8%) men; average age 64.3 years; duration of diabetes 5.5 years. 906 (35.2%) women: average age 61.6 years; duration 4.7 years. The cumulative mean QALY (95% CI) gain: 0.054 (0.044-0.062) years. Mean difference in cost: –£118.72 (–£150.16 to –£54.16) over ten years. Increasing MDMW costs (10%): –£50.49 (–£82.24-£14.14). Decreasing MDMW costs (10%): –£186.95 (–£218.53 to –£122.51). Conclusions: MDMW is “dominant” over usual care (cost-saving and life improving) in supporting self-management in people with type 2 diabetes not treated with insulin. Wider use may result in significant cost savings through delay or reduction of long-term complications and improved QALYs in Scotland and other countries. MDMW may be among the most cost-effective interventions currently available to support diabetes.Keywords
Funding Information
- Scottish Government Health and Social Care Directorate (N/A)
This publication has 17 references indexed in Scilit:
- Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort StudyDiabetes Therapy, 2017
- Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJMIR mHealth and uHealth, 2017
- MyDiabetesMyWayJournal of Diabetes Science and Technology, 2016
- Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefitDiabetic Medicine, 2016
- Uptake and Effects of the e-Vita Personal Health Record with Self-Management Support and Coaching, for Type 2 Diabetes Patients Treated in Primary CareJournal of Diabetes Research, 2016
- Validation of the UKPDS 82 risk equations within the Cardiff Diabetes ModelCost Effectiveness and Resource Allocation, 2015
- Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World EvidenceValue in Health, 2015
- UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82Diabetologia, 2013
- Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costsDiabetic Medicine, 2012
- The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes PreventionDiabetes Care, 2012